John E. (Jack) Bailey Jr., Director at G1 Therapeutics, Inc. (GTHX), bought 8,000 shares at $12.83 ($102K) on 2020-11-11, disclosed to the SEC on 2020-11-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.76 | 4,000 | $51K | 49.9% |
| 2 | $12.83 | 4,000 | $51K | 50.1% |
| Total | $12.79 avg | 8,000 | $102K | 100% |
| Filing → |
| GTHX | SELL | 2024-01-08 | $36K | — | Filing → |
| GTHX | SELL | 2024-01-02 | $216K | — | Filing → |
| GTHX | SELL | 2023-07-07 | $7K | — | Filing → |